Table 3 Recommended approach to the management of hyperglycaemia in patients with type 2 diabetes: modulation of the intensiveness of glucose lowering based on patient and disease features, a broad construct to guide clinical decision-makinga
Patient/disease features | ⇐ HbA1c 53 mmol/mol (7.0%) ⇒ | |
|---|---|---|
More stringent | Less stringent | |
Risks potentially associated with hypoglycaemia and other adverse drug effects | Low | High |
Disease duration | Newly diagnosed | Long-standing |
Life expectancy | Long | Short |
Important co-morbidities | Absent | Severe |
Established vascular complications | Absent | Severe |
Patient attitude and expected treatment efforts | Highly motivated, adherent, excellent self-care capacities | Less motivated, non-adherent, poor self-care capacities |
Resources and support system | Readily available | Limited |
